Shacham-Shmueli, Einat <br/><br/>
Phase I trial of sorafenib in combination with 5-fluorouracil/leucovorin in advanced solid tumors.  [electronic resource] 

 -  Journal of clinical pharmacology  May 2012 
 - 656-69 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1552-4604 
<br/><br/><label>Standard No.: </label>10.1177/0091270011404027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Area Under Curve<br/>Benzenesulfonates--administration & dosage<br/>Drug Administration Schedule<br/>Drug Interactions<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Infusions, Intravenous<br/>Injections, Intravenous<br/>Israel<br/>Leucovorin--administration & dosage<br/>Male<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Protein Kinase Inhibitors--administration & dosage<br/>Pyridines--administration & dosage<br/>Sorafenib<br/>Treatment Outcome<br/>Vitamin B Complex--administration & dosage